Craft

IDT Australia

Stock Price

$0.1

2024-10-18

Market Capitalization

$55.9 M

2024-10-18

Revenue

$19.2 M

FY, 2025

IDT Australia Summary

Company Summary

Overview
IDT Australia is a science and technology company providing pharmaceutical services. It specializes in the manufacture of API (active pharmaceutical ingredients) and finished dose products (including beta lactams), microbiological and analytical testing, clinical packaging, and pharmacy services.
Type
Public
Status
Active
Founded
1975
HQ
Boronia, AU | view all locations
Website
https://en.idtaus.com.au/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Ancila Desai

    Ancila Desai, Chief Financial Officer, Company Secretary

  • Jim Sosic

    Jim Sosic, Vice President Operations, Supply and Infrastructure

  • Paul McDonald

    Paul McDonald, Head of Quality and Development

  • David Sparling

    David Sparling, Chief Executive Officer

LocationsView all

1 location detected

  • Boronia, VIC HQ

    Australia

    45 Wadhurst Dr

IDT Australia Financials

Summary Financials

Revenue (H1, 2026)
$9.7M
Gross profit (H1, 2026)
$8.6M
Net income (H1, 2026)
($1.3M)
Cash (H1, 2026)
$1.9M
EBIT (H1, 2026)
($804.0K)
Enterprise value
$63.8M

Footer menu